Disease Areas

At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine. In 2015, our products reached an estimated 520 million patients and our aspiration is to reach 1 billion people.

In addition to the global #1 ranking in biosimilars¹ and generic antibiotics², dermatology² and transplantation medicines², Sandoz holds leading global positions in areas ranging from generic cardiovascular, central nervous system (CNS), pain and ophthalmology to oncology, respiratory and hormonal therapeutics. Our broad portfolio is backed by a range of state-of-the-art technologies, formulations and devices, including prolonged-release and multiple-unit tablets, creams and gels, orodispersible films, transdermal patches, lyophilized products, implants and inhalers.